Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00547300 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension
A Phase 3 study, sponsored by Forest Laboratories.
- Terminated
- Registry status
- Phase 3
- Development phase
- 49
- Enrollment target
NCT00547300 is a Phase 3 study that was terminated before completion, run by Forest Laboratories. The registered enrollment target is 49 participants.
The verdict
NCT00547300, a Phase 3 study, was terminated before completion, sponsored by Forest Laboratories.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study was to compare the tolerability of nebivolol to metoprolol ER in a general population of patients with mild to moderate hypertension receiving hydrochlorothiazide (HCTZ)
Interventions
- DRUG Nebivolol
- DRUG Metoprolol ER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2007-10-31 |
| Est. Completion | 2008-01-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00547300
The ClinicalTrials.gov registry entry for NCT00547300 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nebivolol is the first listed.
NCT00547300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00547300 about?
NCT00547300 is a clinical study titled "Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension". The purpose of this study was to compare the tolerability of nebivolol to metoprolol ER in a general population of patients with mild to moderate hypertension receiving hydrochlorothiazide (HCTZ)
What is the current status of trial NCT00547300?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 49 participants. The study started on 2007-10-31. Estimated completion is 2008-01-02.
What interventions are being tested in trial NCT00547300?
The interventions under investigation include: Nebivolol (DRUG), Metoprolol ER (DRUG).
Who is sponsoring clinical trial NCT00547300?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.